The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
本公开的特征是由原药二聚体形成的药物组合物,用于延长给药时间和治疗疾病或病症。
GLASS FORMULATIONS AND USES THEREOF
申请人:Interface Biologics, Inc.
公开号:US20190275167A1
公开(公告)日:2019-09-12
The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.